What should you know about WT1 immunohistochemistry?

Immunohistochemistry applies selected antibodies to tissue taken during a Biopsy. If the target protein is present, a chemical reaction creates a visible stain that the pathologist evaluates under a microscope. WT1 is one marker in a panel, rather than a stand-alone answer. Its pattern, strength and location in cells are considered alongside the tissue appearance and other markers.

A WT1 result can support the classification of a tumour and help distinguish between possible origins. A positive or negative result does not, by itself, prove or exclude cancer, identify the stage or choose a treatment. Interpretation varies with the tumour type and the laboratory method.

Ask for the complete pathology report, including the specimen source, the WT1 staining pattern and the other markers tested. Ask how the finding fits the microscope description and imaging. If the wording is unclear or the diagnosis has major treatment implications, request a pathology discussion or ask whether a Second Opinion would add value.

The stain is performed on tissue and does not create symptoms after the report is issued. Seek care according to the procedure that obtained the sample. Contact the team for increasing pain, redness, swelling, fever or bleeding at the biopsy site, and seek urgent help for severe bleeding, fainting or sudden severe illness.

Ask what WT1 means in your specific tumour, whether the staining is nuclear or another pattern, which additional markers were used, and whether the result changes the diagnosis or treatment plan. Ask who can explain the report if pathology terms remain difficult to follow.